2020年8月17日

Teva, Cipla Appear to Settle Generic Delay Suit Over Sensipar

分享
Cipla Ltd. dropped an antitrust lawsuit against Teva Pharmaceutical Industries Ltd., following an apparent settlement of claims in Delaware federal court that Teva stopped selling its generic version of Amgen Inc.'s blockbuster calcium reducer Sensipar because of an anti-competitive patent deal.

相关服务及行业

及时掌握我们的最新见解

见证我们如何使用跨学科的综合方法来满足客户需求
[订阅]